News
Information from Lifecare – August 2022
Posted: 08/08/2022
Independent experts from the European Commission’s Innovation Radar have reviewed Lifecares technology in the EU funded project FORGETDIABETES. The review concludes that Lifecare’s innovations are “Market Ready” and considered among the top 14% of innovations in scientific projects receiving financial grants from the European Commission.
Lifecare is part of the EU funded research project FORGETDIABETES, where the company in cooperation with German, Italian and French academic institutions aim to develop an implantable artificial bionic pancreas. Lifecares primary tasks in the project is to develop the sensing element – an “implantable intra peritoneal sensor”, as well as an in-vitro test system for the artificial pancreas beening developed, through Lifecares wholly owned subsidiary Lifecare Laboratory (previously Pfützner Science & Health Institute). In 2020 the European Commission granted the project funding of 3,9 million EUR under the Horizon 2020 program.
The European Commission has established the Innovation Radar as an initiative to identify high potential innovations in EU-funded research. One of the goals of the Innovation Radar is to ensure information of EU-funded research projects. The Innovation Radar analyze information and data gathered by independent experts involved in reviewing ongoing projects funded by the EU, including the independent expert’s views on innovations and market potential. The Innovation Radar methodology is explained here: https://www.innoradar.eu/methodology/#maturity-info
Lifecare’s involvement in the project FORGETDIABETES involves two key innovation tasks.
- Lifecare AS is responsible for the development and customization of Lifecares proprietary osmotic pressure-based sensor for glucose monitoring in the subcutaneous area, into an “implantable intra peritoneal sensor”. The sensor represents a critical component for the development of an artificial pancreas.
- Lifecare Laboratory GmbH is a project participant - independent of the mother company - responsible for the development of an in-vitro test system for the sensor and an insulin pump as part of the planned artificial pancreas. As part of this task, Lifecare Laboratory have developed an “In-vitro test bench for dynamic interference testing of glucose sensors”.